HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Thai, T.-H. Articles by Kearney, J. F. Search for Related Content PubMed PubMed Citation Articles by Thai, T.-H. Articles by Kearney, J. F.

Distinct and Opposite Activities of Human Terminal Deoxynucleotidyltransferase Splice Variants¹

To-Ha Thai^2,*, and John F. Kearney^3,*,

^* Division of Developmental and Clinical Immunology, and Department of Microbiology, University of Alabama, Birmingham, AL 35294

Evidence for potential human TdT (hTdT) isoforms derived from hTdT genomic sequences led us to identify the short isoform (hTdTS), as well as mature long transcripts containing exon XII (hTdTL1) and another including exon VII (hTdTL2) in lymphoid cells. Normal B and T lymphocytes express exclusively hTdTS and hTdTL2, whereas hTdTL1 expression appears to be restricted to transformed lymphoid cell lines. In in vitro recombination and primer assays, both long isoforms were shown to have 3'5' exonuclease activity. Overexpression of hTdTS or hTdTL2 greatly reduced the efficiency of recombination, which was reverted to normal levels by the simultaneous expression of both enzymes. Therefore, alternative splicing may prevent the adverse effects of unchecked elongation or diminution of coding ends during V(D)J recombination, thus affecting the survival of a B or T cell precursor during receptor gene rearrangements. Finally, the newly discovered hTdT isoforms should be considered in future screening of human leukemias.

This article has been cited by other articles:

				S. Maezawa, T. Hayano, K. Koiwai, R. Fukushima, K. Kouda, T. Kubota, and O. Koiwai Bood POZ containing gene type 2 is a human counterpart of yeast Btb3p and promotes the degradation of terminal deoxynucleotidyltransferase. Genes Cells, May 1, 2008; 13(5): 439 - 457. [Abstract] [Full Text] [PDF]

				J. M. Murray, J. P. O'Neill, T. Messier, J. Rivers, V. E. Walker, B. McGonagle, L. Trombley, L. G. Cowell, G. Kelsoe, F. McBlane, et al. V(D)J Recombinase-Mediated Processing of Coding Junctions at Cryptic Recombination Signal Sequences in Peripheral T Cells during Human Development J. Immunol., October 15, 2006; 177(8): 5393 - 5404. [Abstract] [Full Text] [PDF]

				P. Wang, B. Yan, J.-t. Guo, C. Hicks, and Y. Xu Structural genomics analysis of alternative splicing and application to isoform structure modeling PNAS, December 27, 2005; 102(52): 18920 - 18925. [Abstract] [Full Text] [PDF]